Tian Ruixiang Holdings Ltd (TIRX) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 4.02M | 3.04M | 178.34K | 519.39K | 724.86K | 406 | 946 | 1.15K | 1.64K | 2.54M | 707.79K | 919 |
| Revenue Growth % | 2156.62% | 485.5% | -75.4% | 127744.7% | 76552.26% | -64.79% | -42.23% | -99.95% | -99.77% | 276398.27% | 65253.37% | -55.29% |
| Medical Costs & Claims | 599.92K | 0 | 0 | -1.09M | 362.43K | 0 | 0 | 0 | 0 | 178.03K | 355.71K | 333 |
| Medical Cost Ratio % | 14.91% | 0% | 0% | -209.54% | 50% | 0% | 0% | 0% | 0% | 7% | 50.26% | 36.24% |
| Gross Profit | 0 | 0 | 178.34K | 1.61M | 362.43K | 406 | 946 | 1.15K | 1.64K | 2.36M | 352.08K | 586 |
| Gross Margin % | 0% | 0% | 100% | 309.54% | 50% | 100% | 100% | 100% | 100% | 93% | 49.74% | 63.76% |
| Gross Profit Growth % | -100% | -100% | -50.79% | 395634.79% | 38226.18% | -64.79% | -42.23% | -99.95% | -99.54% | 403013.17% | 46835.15% | -69.85% |
| Operating Expenses | 0 | 0 | 3.14M | 2.7M | 1.33K | 1.94K | 4.8K | 2.99K | 2.04K | 1.71M | 355.71K | 1.37K |
| OpEx / Revenue % | 0% | 0% | 1761.29% | 519.09% | 0.18% | 478.82% | 506.98% | 259.19% | 124.31% | 67.46% | 50.26% | 149.51% |
| Depreciation & Amortization | 21.04K | 100.97K | 67.73K | 23.41K | 56.35K | 5 | 12 | 7 | 13 | 14.15K | 27.36K | 7 |
| Combined Ratio % | 14.91% | 0% | 1761.29% | 309.54% | 50.18% | 478.82% | 506.98% | 259.19% | 124.31% | 74.46% | 100.51% | 185.75% |
| Operating Income | -271.04K | 1.86M | -2.96M | -1.09M | -1.93M | -1.06K | -3.88K | -1.79K | -465 | 927.93K | -367.79K | -153 |
| Operating Margin % | -6.73% | 61.11% | -1661.29% | -209.54% | -265.98% | -262.32% | -410.15% | -154.94% | -28.41% | 36.51% | -51.96% | -16.65% |
| Operating Income Growth % | 90.85% | 270.76% | -53.67% | -102106.52% | -49584.93% | 40.46% | -733.61% | -100.19% | 99.87% | 606826.17% | -143985.61% | -120.68% |
| EBITDA | -250K | 1.96M | -2.9M | -1.06M | -1.87M | -1.06K | -3.87K | -1.78K | -452 | 942.08K | -340.43K | -146 |
| EBITDA Margin % | -6.21% | 64.43% | -1623.31% | -205.04% | -258.21% | -260.84% | -408.88% | -154.33% | -27.61% | 37.07% | -48.1% | -15.89% |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 367.78K | 0 |
| Pretax Income | -387.11K | -1.35M | -2.59M | -826.39K | -1.47M | -1.18K | -3.48K | -1.52K | -397 | 991.23K | -462.16K | 15 |
| Pretax Margin % | -9.62% | -44.51% | -1452.94% | -159.11% | -202.28% | -290.15% | -368.08% | -131.98% | -24.25% | 39% | -65.3% | 1.63% |
| Income Tax | 109.59K | 28.02K | 14.1K | 141.34K | 0 | 2 | 21 | 18 | 7 | 121.42K | 4.63K | 91 |
| Effective Tax Rate % | -28.31% | -2.07% | -0.54% | -17.1% | 0% | -0.17% | -0.6% | -1.18% | -1.76% | 12.25% | -1% | 606.67% |
| Net Income | -496.7K | -1.38M | -2.61M | 3.62M | 2.97M | -1.18K | -3.5K | -1.54K | -404 | 869.81K | -235.71K | -76 |
| Net Margin % | -12.34% | -45.43% | -1460.85% | 697.89% | 410.36% | -290.64% | -370.4% | -133.54% | -24.68% | 34.22% | -33.3% | -8.27% |
| Net Income Growth % | 80.94% | -138.12% | -187.59% | 307164.68% | 84995.97% | 23.38% | -767.39% | -100.18% | 99.83% | 1144707.33% | -93716.65% | -113.08% |
| EPS (Diluted) | -0.01 | -0.04 | -0.13 | -0.72 | 0.25 | -0.00 | -0.00 | -0.00 | -0.00 | 0.15 | -0.06 | 0.00 |
| EPS Growth % | 92.31% | 94.17% | -152% | - | - | - | - | -100.12% | 99.86% | - | - | - |
| EPS (Basic) | -0.01 | -0.04 | -0.13 | 0.29 | 0.25 | -0.00 | -0.00 | -0.00 | -0.00 | 0.19 | -0.06 | 0.00 |
| Diluted Shares Outstanding | 50M | 47.69M | 19.41M | 12.67M | 11.9M | 10.91M | 9.84M | 8.53M | 5.25M | 5.82M | 4M | 4M |